News: Company News

​Agilex Biolabs   →  News   →  Company News
17
May
Date May 17, 2021
Categories Company News

Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research

Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed and cost advantages working with their company TetraQ toxicology for pre-clinical research in Australia.

TetraQ is a NATA-accredited, GLP-recognised rodent toxicology facility.
Read More
Author Agilex Biolabs
07
Apr
Date April 7, 2021
Categories Company News

Agilex Biolabs Buys Leading Biolab TetraQ as Part of APAC Expansion Plans

Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced the purchase of leading biolab TetraQ, based out of the University of Queensland.

Agilex Biolabs CEO Jason Valentine said the Board and senior management at Agilex Biolabs were extremely pleased with the purchase of such a high-calibre bioanalytics company.

“TetraQ complements the Agilex Biolabs work in Australia and APAC with its expert staff and years of experience in regulated bioanalytical services,” he said.
Read More
Author Agilex Biolabs
05
Jan
Date January 5, 2021
Categories Company News

Agilex Biolabs takes delivery of two Sciex API 6500+™ LC-MS/MS systems

Agilex Biolabs is the leading bioanalytical laboratory in Asia-Pacific with the most advanced platforms for sensitive technologies. They include Sciex API 6500+ LC-MS/MS, Sciex API 4000 LC-MS/MS systems; Gyrolab™ Xplore, Luminex MAGPIX xPONENT ™, MSD Quickplex 120 and BD FACSymphony™ A3 20 colour flow cytometry analysers, so we have the capability to deliver any sized project.
Read More
Author Agilex Biolabs
1 2 3 4